🇺🇸 FDA
Patent

US 7862811

Protease inhibition for prevention or treatment of heart failure

granted A61KA61K38/57

Quick answer

US patent 7862811 (Protease inhibition for prevention or treatment of heart failure) held by The Regents of the University of Colorado expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/57